Contents hide 1 Differentiated Thyroid Cancer 2 Renal Cell Carcinoma 2.1 Combination therapy with everolimus 2.2 Combination therapy with pembrolizumab 3 Hepatocellular Carcinoma 3.1 Dose based on actual body weight 4 Endometrial Cancer 5 Dosage Modifications 5.1 DTC dose reductions 5.2 RCC or endometrial carcinoma dose reductions 5.2.1 Dose modification of everolimus in RCC 5.2.2 Dose modification of pembrolizumab in endometrial carcinoma 5.3 HCC dose reductions 5.3.1 First occurrence 5.3.2 Second occurrence 5.3.3 Third occurrence 5.4 Hypertension 5.5 Cardiac dysfunction 5.6 Arterial thrombotic event 5.7 Hepatoxicity 5.8 Proteinuria 5.9 GI toxicity 5.10 Renal failure or impairment 5.11 QTc prolongation 5.12 … Continue reading Generic (Lenvatinib) Lyvioni-10